Recent advances in treatment of retinitis pigmentosa

Current Stem Cell Research and Therapy

Volumn 10, Issue 3, 2015, Pages 258-265

  He, Yuxi ^a   Zhang, Yan ^a   Su, Guanfang ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Cell transplantation; Cytokine therapy; Gene therapy; Hyperbaric oxygen therapy; Nutrition therapy; Retinitis pigmentosa

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; NERVE GROWTH FACTOR; RETINOL; VALPROIC ACID; XANTHOPHYLL;

ARTICLE; DIET THERAPY; GENE THERAPY; HUMAN; HYPERBARIC OXYGEN; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINITIS PIGMENTOSA; STEM CELL TRANSPLANTATION; VITAMIN SUPPLEMENTATION; ANIMAL; CELL TRANSPLANTATION; ELECTROSTIMULATION THERAPY; GENETICS; PATHOLOGY;

ANIMALS; CELL TRANSPLANTATION; ELECTRIC STIMULATION THERAPY; GENETIC THERAPY; HUMANS; RETINITIS PIGMENTOSA;

EID: 84928955268     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666141027103552     Document Type: Article

References (114)

1. Hamel CP. Retinitis pigmentosa. Orphanet J Rare Dis 2006; 1: 40.
2. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis 2007; 2: 7.
3. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006; 368(9549): 1795-809.
4. Xu L, Hu L, Ma K, Li J, Jonas JB. Prevalence of retinitis pigmentosa in urban and rural adult Chinese: The Beijing Eye Study. Eur J Ophthalmol 2006; 16(6): 865-6.
5. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res 2003; 22(5): 607-55.
6. Petrs-Silva H, Linden R. Advances in gene therapy technologies to treat retinitis pigmentosa. Clin Ophthalmol 2014; 8: 127-36.
7. Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res 2010; 29(5): 335-75.
8. Anasagasti A, Irigoyen C, Barandika O, Lopez de Munain A, Ruiz-Ederra J. Current mutation discovery approaches in Retinitis Pigmentosa. Vision Res 2012; 75: 117-29.
9. Boughman JA, Fishman GA. A genetic analysis of retinitis pigmentosa. Br J Ophthalmol 1983; 67(7): 449-54.
10. Conlon TJ, Deng WT, Erger K, et al.Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev 2013; 24(1): 23-8.
11. Anasagasti A, Irigoyen C, Barandika O, Lopez de Munain A, Ruiz-Ederra J. Gene therapy in the rd6 mouse model of retinal degeneration. Adv Exp Med Biol 2014; 801: 711-8.
12. Millington-Ward S, Chadderton N, O'Reilly M, et al.Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa. Mol Ther 2011; 19(4): 642-9.
13. Mao HY, Gorbatyuk MS, Rossmiller B, Hauswirth WW, Lewin AS. Long-Term Rescue of Retinal Structure and Function by Rhodopsin RNA Replacement with a Single Adeno-Associated Viral Vector in P23H RHO Transgenic Mice. Hum Gene Ther 2012; 23(4): 356-66.
14. Ali RR, Sarra GM, Stephens C, et al.Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 2000; 25(3): 306-10.
15. Sarra GM, Stephens C, de Alwis M, et al.Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet 2001; 10(21): 2353-61.
16. Schlichtenbrede FC, MacNeil A, Bainbridge JW, et al.Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 2003; 10(6): 523-7.
17. Sahel JA, Roska B. Gene therapy for blindness. Annu Rev Neurosci. 2013; 36: 467-88.
18. Cai X, Conley SM, Naash MI. Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa. Adv Exp Med Biol 2010; 664: 611-9.
19. Wert KJ, Davis RJ, Sancho-Pelluz J, Nishina PM, Tsang SH. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet 2013; 22(3): 558-67.
20. Cideciyan AV, Jacobson SG, Beltran WA, et al.Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A 2013; 110(6): E517-25.
21. Liu MM, Tuo JS, Chan CC. Gene therapy for ocular diseases. Brit J Ophthalmol 2011; 95(5): 604-12.
22. Tosi J, Sancho-Pelluz J, Davis RJ, et al.Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa. Exp Biol Med (Maywood) 2011; 236(10): 1211-7.
23. Pang JJ, Boye SL, Kumar A, et al.AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation. Invest Ophthalmol Vis Sci 2008; 49(10): 4278-83.
24. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vovo. Brain Res 1993; 602(2): 304-17.
25. LaVail MM, Yasumura D, Matthes MT, et al.Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39(3): 592-602.
26. Chong NH, Alexander RA, Waters L, Barnett KC, Bird AC, Luthert PJ. Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci 1999; 40(6): 1298-305.
27. Liang FQ, Dejneka NS, Cohen DR, et al.AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. Mol Ther 2001; 3(2): 241-8.
28. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ. Prolonged delivery of brain-derived neurotrophic factor by adenovirusinfected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 1998; 95(7): 3978-83.
29. McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001; 4(6): 622-9.
30. Tao W, Wen R, Goddard MB, et al.Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002; 43(10): 3292-8.
31. Thanos CG, Bell WJ, O'Rourke P, et al.Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device. Tissue Eng 2004; 10(11-12): 1617-22.
32. Harada T, Harada C, Kohsaka S, et al.Microglia-Muller glia cell interactions control neurotrophic factor production during lightinduced retinal degeneration. J Neurosci 2002; 22(21): 9228-36.
33. Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res 2005; 45(12): 1491-500.
34. Gauthier R, Joly S, Pernet V, Lachapelle P, Di Polo A. Brainderived neurotrophic factor gene delivery to muller glia preserves structure and function of light-damaged photoreceptors. Invest Ophthalmol Vis Sci 2005; 46(9): 3383-92.
35. Azadi S, Johnson LE, Paquet-Durand F, et al.CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina. Brain Res 2007; 1129(1): 116-29.
36. Buch PK, MacLaren RE, Duran Y, et al.In contrast to AAVmediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol Ther 2006; 14(5): 700-9.
37. Andrieu-Soler C, Aubert-Pouessel A, Doat M, et al.Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis 2005; 11: 1002-11.
38. O'Driscoll C, O'Connor J, O'Brien CJ, Cotter TG. Basic fibroblast growth factor-induced protection from light damage in the mouse retina in vovo. J Neurochem 2008; 105(2): 524-36.
39. Miyazaki M, Ikeda Y, Yonemitsu Y, et al.Simian lentiviral vectormediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats. Gene Ther 2003; 10(17): 1503-11.
40. Machida S, Tanaka M, Ishii T, Ohtaka K, Takahashi T, Tazawa Y. Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats. Invest Ophthalmol Vis Sci 2004; 45(11): 4174-82.
41. Lambiase A, Aloe L. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol 1996; 234 Suppl 1: S96-100.
42. Goncalves RM, Lemos CO, Leal IC, et al.Comparing conventional and supercritical extraction of (-)-mammea A/BB and the antioxidant activity of Calophyllum brasiliense extracts. Molecules 2013; 18(6): 6215-29.
43. Liang FQ, Aleman TS, Dejneka NS, et al.Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 2001; 4(5): 461-72.
44. Kent TL, Glybina IV, Abrams GW, Iezzi R. Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat. Invest Ophthalmol Vis Sci 2008; 49(1): 372-9.
45. Kauper K, McGovern C, Sherman S, et al.Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases. Invest Ophthalmol Vis Sci 2012; 53(12): 7484-91.
46. Wilson RB, Kunchithapautham K, Rohrer B. Paradoxical role of BDNF: BDNF+/-retinas are protected against light damagemediated stress. Invest Ophthalmol Vis Sci 2007; 48(6): 2877-86.
47. Tian C, Weng CC, Yin ZQ. BDNF improves the efficacy ERG amplitude maintenance by transplantation of retinal stem cells in RCS rats. Adv Exp Med Biol 2010; 664: 375-84.
48. Girman SV, Wang S, Lund RD. Cortical visual functions can be preserved by subretinal RPE cell grafting in RCS rats. Vision Res 2003; 43(17): 1817-27.
49. Lawrence JM, Sauve Y, Keegan DJ, et al.Schwann cell grafting into the retina of the dystrophic RCS rat limits functional deterioration. Royal College of Surgeons. Invest Ophthalmol Vis Sci 2000; 41(2): 518-28.
50. McGill TJ, Cottam B, Lu B, et al.Transplantation of human central nervous system stem cells -neuroprotection in retinal degeneration. Eur J Neurosci 2012; 35(3): 468-77.
51. Huo SJ, Li YC, Xie J, et al.Transplanted olfactory ensheathing cells reduce retinal degeneration in Royal College of Surgeons rats. Curr Eye Res 2012; 37(8): 749-58.
52. Tian C, Zhao T, Zeng Y, Yin ZQ. Increased Muller cell dedifferentiation after grafting of retinal stem cell in the sub-retinal space of Royal College of Surgeons rats. Tissue Eng Part A 2011; 17(19-20): 2523-32.
53. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002; 8(9): 1004-10.
54. Haruta M, Sasai Y, Kawasaki H, et al. In vitro and in vovo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest Ophthalmol Vis Sci 2004; 45(3): 1020-5.
55. Pinilla I, Cuenca N, Sauve Y, Wang SM, Lund RD. Preservation of outer retina and its synaptic connectivity following subretinal injections of human RPE cells in the Royal College of Surgeons rat. Exp Eye Res 2007; 85(3): 381-92.
56. Sauve Y, Girman SV, Wang S, Keegan DJ, Lund RD. Preservation of visual responsiveness in the superior colliculus of RCS rats after retinal pigment epithelium cell transplantation. Neuroscience 2002; 114(2): 389-401.
57. Yang Y, Mohand-Said S, Leveillard T, Fontaine V, Simonutti M, Sahel JA. Transplantation of Photoreceptor and Total Neural Retina Preserves Cone Function in P23H Rhodopsin Transgenic Rat. PLoS One 2010; 5(10): e13469.
58. Singh MS, Issa PC, Butler R, et al.Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci USA 2013; 110(3): 1101-6.
59. Tao YX, Xu HW, Yin ZQ, FitzGibbon T. Noggin induces human bone marrow-derived mesenchymal stem cells to differentiate into neural and photoreceptor cells. Indian J Exp Biol 2010; 48(5): 444-52.
60. Nadri S, Kazemi B, Eeslaminejad MB, Yazdani S, Soleimani M. High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds. Mol Biol Rep 2013; 40(6): 3883-90.
61. Nadri S, Yazdani S, Arefian E, et al.Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane. Neurosci Lett 2013; 541: 43-8.
62. Lund RD, Wang SM, Klimanskaya I, et al.Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006; 8(3): 189-99.
63. Kicic A, Shen WY, Wilson AS, Constable IJ, Robertson T, Rakoczy PE. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci 2003; 23(21): 7742-9.
64. Aramant RB, Seiler MJ, Ball SL. Successful cotransplantation of intact sheets of fetal retina with retinal pigment epithelium. Invest Ophthalmol Vis Sci 1999; 40(7): 1557-64.
65. Gouras P, Flood MT, Kjedbye H, Bilek MK, Eggers H. Transplantation of cultured human retinal epithelium to Bruch's membrane of the owl monkey's eye. Curr Eye Res 1985; 4(3): 253-65.
66. Tian CY, Zhao TT, Zeng YX, Yin ZQ. Retinal repair by transplantation of photoreceptor precursors. Nature 2006; 444(7116): 203-7.
67. Qiu G, Seiler MJ, Mui C, et al.Photoreceptor differentiation and integration of retinal progenitor cells transplanted into transgenic rats. Exp Eye Res 2005; 80(4): 515-25.
68. West EL, Pearson RA, Barker SE, et al.Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 2010; 28(11): 1997-2007.
69. Trounson A. Human embryonic stem cells: mother of all cell and tissue types. Reprod Biomed Online 2002; 4 Suppl 1: 58-63.
70. Yanai A, Laver C, Joe AW, Gregory-Evans K. Efficient production of photoreceptor precursor cells from human embryonic stem cells. Methods Mol Biol 2013.
71. Wang NK, Tosi J, Kasanuki JM, et al.Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa.Transplantation 2010; 89(8): 911–9.
72. Idelson M, Alper R, Obolensky A, et al.Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009; 5(4): 396-408.
73. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18(4): 399-404.
74. Cowan CA, Klimanskaya I, McMahon J, et al.Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004; 350(13): 1353-6.
75. Yu JY, Vodyanik MA, Smuga-Otto K, et al.Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858): 1917-20.
76. Jin ZB, Okamoto S, Xiang P, Takahashi M. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cell Transl Med 2012; 1(6): 503-9.
77. Tucker BA, Mullins RF, Streb LM, et al.Patient-specific iPSCderived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. Elife 2013; 2.
78. Li Y, Tsai YT, Hsu CW, et al.Long-term Safety and Efficacy of Human-Induced Pluripotent Stem Cell (iPS) Grafts in a Preclinical Model of Retinitis Pigmentosa. Mol Med 2012; 18(9): 1312-9.
79. Puzio-Kuter AM, Levine AJ. Stem cell biology meets p53. Nat Biotechnol 2009; 27(10): 914-5.
80. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5): 267-74.
81. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22(7): 1338-45.
82. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103(5): 1669-75.
83. Ghorbani A, Jalali SA, Varedi M. Isolation of adipose tissue mesenchymal stem cells without tissue destruction: A nonenzymatic method. Tissue Cell 2014; 46(1): 54-8.
84. Inoue Y, Iriyama A, Ueno S, et al.Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 2007; 85(2): 234-41.
85. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal Injection of Autologous Bone Marrow-Derived Mononuclear Cells for Hereditary Retinal Dystrophy a Phase I Trial. Retina 2011; 31(6): 1207-14.
86. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Acta Ophthalmol 2008; 86(2): 225-6.
87. Klassen HJ, Ng TF, Kurimoto Y, et al.Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 2004; 45(11): 4167-73.
88. Ruitenberg MJ, Vukovic J, Sarich J, Busfield SJ, Plant GW. Olfactory ensheathing cells: characteristics, genetic engineering, and therapeutic potential. J Neurotrauma 2006; 23(3-4): 468-78.
89. Ramon-Cueto A, Avila J. Olfactory ensheathing glia: properties and function. Brain Res Bull 1998; 46(3): 175-87.
90. Huo SJ, Li Y, Raisman G, Yin ZQ. Transplanted olfactory ensheathing cells reduce the gliotic injury response of Muller cells in a rat model of retinitis pigmentosa. Brain Res 2011; 1382: 238-44.
91. Gamm DM, Wang S, Lu B, et al.Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One 2007; 2(3): e338.
92. Wang S, Girman S, Lu B, et al.Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci 2008; 49(7): 3201-6.
93. Behrstock S, Ebert A, McHugh J, et al.Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 2006; 13(5): 379-88.
94. Klein SM, Behrstock S, McHugh J, et al.GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005; 16(4): 509-21.
95. Lu B, Wang S, Girman S, McGill T, Ragaglia V, Lund R. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res 2010; 91(3): 449-55.
96. Nei M. Estimation of average heterozygosity and genetic distance from a small number of individuals. Genetics 1978; 89(3): 583-90.
97. Selander RK, Kaufman DW. Genic variability and strategies of adaptation in animals. Proc Natl Acad Sci USA 1973; 70(6): 1875-7.
98. Hambright D, Park KY, Brooks M, McKay R, Swaroop A, Nasonkin IO. Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in unimmunosuppressed mouse retina. Mol Vis 2012; 18: 920-36.
99. MacLaren RE, Buch PK, Smith AJ, et al.CNTF gene transfer protects ganglion cells in rat retinae undergoing focal injury and branch vessel occlusion. Exp Eye Res 2006; 83(5): 1118-27.
100. Bartsch U, Oriyakhel W, Kenna PF, et al.Retinal cells integrate into the outer nuclear layer and differentiate into mature photoreceptors after subretinal transplantation into adult mice. Exp Eye Res 2008; 86(4): 691-700.
101. Vingolo EM, Rocco M, Grenga P, Salvatore S, Pelaia P. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2008; 246(1): 93-8.
102. Vingolo EM, Pelaia P, Forte R, Rocco M, Giusti C, Rispoli E. Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa? Doc Ophthalmol 1999; 97(1): 33-9.
103. Perusek L, Maeda T. Vitamin A Derivatives as Treatment Options for Retinal Degenerative Diseases. Nutrients 2013; 5(7): 2646-66.
104. Berson EL, Rosner B, Sandberg MA, et al.A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993; 111(6): 761-72.
105. Radu RA, Yuan Q, Hu J, et al.Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci 2008; 49(9): 3821-9.
106. Tsubura A, Yuri T, Yoshizawa K, Uehara N, Takada H. Role of fatty acids in malignancy and visual impairment: epidemiological evidence and experimental studies. Histol Histopathol 2009; 24(2): 223-34.
107. Nguyen CT, Vingrys AJ, Bui BV. Dietary omega-3 fatty acids and ganglion cell function. Invest Ophthalmol Vis Sci 2008; 49(8): 3586-94.
108. Wheaton DK, Birch DG, Fish GE, et al.Safety Assessment of Docosahexaenoic Acid in X-linked Retinitis Pigmentosa: The 4-year DHAX trial. Invest Ophthalmol Vis Sci 2014; 55(8): 4958-66.
109. Hoffman DR, Hughbanks-Wheaton DK, Pearson NS, et al.Fouryear placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX Trial): A randomized clinical trial. JAMA Ophthalmol 2014; 132(7): 866-73.
110. Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC ophthalmology 2006; 6: 23.
111. Berson EL, Rosner B, Sandberg MA, et al.Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2010; 128(4): 403-11.
112. Kumar A, Midha N, Gogia V, Gupta S, Sehra S, Chohan A. Efficacy of oral valproic acid in patients with retinitis pigmentosa. J Ocul Pharmacol Ther 2014; 30(7): 580-6.
113. Bhalla S, Joshi D, Bhullar S, Kasuga D, Park Y, Kay CN. Longterm follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid. Br J Ophthalmol 2013; 97(7): 895-9.
114. Sisk RA. Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa. Brit J Ophthalmol 2012; 96(8): 1154-5.